7

MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with
Page 2: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with
Joy Houck
Page 3: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with
Page 4: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with
Page 5: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with
Page 6: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with
Page 7: MAN Agenda2012-Technology strikeforce Agenda2012-Technology strikef… · and challenges for pharma companies. Pharma may be at risk for being disengaged from the conversation with

!